Home・Listă Acțiuni・CorMedix Inc

CorMedix Inc

Închisă

SectorSănătate

7.84 -2.12

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

7.82

Maxim

7.89

Indicatori cheie
By Trading Economics
Venit	25M 39M
Vânzări	-1.2M 127M
P/E Medie Sector	3.89 62.58
EPS	0.35
Marjă de profit	30.293
Angajați	191
EBITDA	-289K 66M

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+77.89% upside

Dividende
By Acuity
Următoarele câștiguri	6 aug. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	9.5M 610M
Deschiderea anterioară	9.96
Închiderea anterioară	7.84

Sentimentul știrilor

By Acuity

72%

28%

301 / 340 Clasament în Healthcare

CorMedix Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

24 iul. 2026, 17:56 UTC

CorMedix Inc's shares are declining, with no specific news identified. The stock remains below its 20-day moving average and near the lower end of its one-month range.

23 iul. 2026, 21:51 UTC

CorMedix Inc shares declined in after-market trading, moving lower despite broader market resilience and turmoil in the bond market. No specific news was identified.

22 iul. 2026, 23:11 UTC

CorMedix Inc. shares are higher in after-market hours, following notable activity. The stock remains below its 20-day moving average.

21 iul. 2026, 19:31 UTC

CorMedix Inc. shares are higher today, reflecting strong buying activity. The stock has gained momentum since Monday's close, despite remaining below its 20-day moving average.

20 iul. 2026, 22:01 UTC

CorMedix Inc shares are higher in after-market trading, reflecting a notable rise since Monday's close, despite being below its 20-day moving average.

Comparație

Modificare preț

CorMedix Inc Așteptări

Obiectiv de preț

By TipRanks

77.89% sus

Prognoză pe 12 luni

Medie 14 USD 77.89%

Maxim 15 USD

Minim 13 USD

În baza a 5 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruCorMedix Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

5 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 5 analiști care au acordat evaluări ale acțiunilor CorMedix Inc - Dist în ultimele 3 luni.

Sentiment

By Acuity

301 / 340 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.